课题基金 / 基金详情

MATERNAL AND NEONATAL IMMUNITY

MATERNAL AND NEONATAL IMMUNITY
母体和新生儿的免疫力
批准号:
2638486
负责人:
THOMAS B TOMASI
金额:
$28.25万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-01 至 2002-03-31

项目摘要

项目成果

THOMAS B TOMASI的其他基金

相似基金

相关文献

中文摘要
翻译
滋养层不能表达MHCII类抗原, 被认为对怀孕期间胎儿的生存至关重要。 因此,很可能是强大的进化压力, 生殖将形成严格的重叠监管控制。 我们 已经确定了两种这样的控制机制, II类表达。上游负调控元件 在鼠II类IA α基因的启动子中, 特异性抑制滋养层的转录。 此外该 II类转录激活因子(CIITA),II类转录激活因子的主要调节因子, II表达在滋养层细胞中不转录, 由IFN-γ或其他细胞因子诱导,在大多数情况下, 其他细胞类型。 该补助金的目标是进一步确定 滋养层细胞无法在体内 表达II类和这对胎儿的生理相关性 坚持不懈 希望这些研究也能阐明 II类表达的控制机制, 其他临床相关领域,如癌症和自身免疫。
英文摘要
The failure of the trophoblast to express MHC class II antigens is believed to be essential for survival of the fetus during pregnancy. It is therefore likely that strong evolutionary pressures to preserve reproduction would develop tight overlapping regulatory controls. We have identified two such control mechanisms which inhibit trophoblast class II expression. An upstream negative regulatory element (IAalphaNRE) in the promoter of the murine class II IAalpha gene that represses transcription specifically in trophoblasts. In addition, the class II transcription activator (CIITA), the master regulator of class II expression is not transcribed in trophoblast cells, nor can it be induced by IFN-gamma or other cytokines that upregulate class II in most other cell types. The goals of this grant are to further define the underlying mechanisms responsible for the inability of the trophoblast to express class II and the physiological relevance of this to fetal persistence. Hopefully, these studies will also elucidate fundamental control mechanisms for class II expression that have application to other areas of clinical relevance such as cancer and autoimmunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic Regulation of Immune Genes in Cancer Treatment and Vaccine Protocols
Epigenetic Regulation of Immune Genes in Cancer Treatment and Vaccine Protocols
Epigenetic Regulation of Immune Genes in Cancer Treatment and Vaccine Protocols
Epigenetic Regulation of Immune Genes in Cancer Treatment and Vaccine Protocols
海外基金